Valisure pressures FDA to recall acne treatments after finding carcinogen

Katherine Lewin

News Reporter

The drug testing company Valisure is back with another citizen petition related to safety concerns, this time requesting the FDA recall acne treatments that contain …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Valisure pressures FDA to recall acne treatments after finding carcinogen

Katherine Lewin

News Reporter

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Val­isure pres­sures FDA to re­call ac­ne treat­ments af­ter find­ing car­cino­gen

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Valisure pressures FDA to recall acne treatments after finding carcinogen